BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7976113)

  • 1. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
    Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
    Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
    Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
    Kedar A; Grow W; Neiberger RE
    Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
    Kantarjian HM; Beran M; O'Brien S; Robertson L; Siddik Z; Yoshida M; Yang LY; Rios MB; Keating MJ; Meyer M
    Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia.
    Liso V; Specchia G; Pavone V; Capalbo S; Dione R
    Acta Haematol; 1990; 83(3):116-9. PubMed ID: 2109448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
    Przepiorka D; Gonzales-Chambers R
    Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
    Chang H; Shih LY
    Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    He H; Li C; Han M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
    Feldman EJ; Alberts DS; Arlin Z; Ahmed T; Mittelman A; Baskind P; Peng YM; Baier M; Plezia P
    J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
    Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
    Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour lysis syndrome with acute renal failure during imatinib therapy.
    Ali R; Ozkalemkas F; Ozkan A; Ozcelik T; Ozkocaman V; Akdag I; Ozan U; Tunali A
    Leuk Res; 2007 Apr; 31(4):573-4. PubMed ID: 16782190
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergency care: the tumor lysis syndrome.
    Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):705-11. PubMed ID: 14974215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lysis syndrome following single-dose mitoxantrone.
    Benekli M; Savaş MC; Güllü IH; Kadayifçi A; Akpek G; Kars A; Güler N; Kansu E; Tekuzman G; Firat D
    Chemotherapy; 1995; 41(6):470-2. PubMed ID: 8529438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
    Nielsen SH; Hasselbalch HC; Birgens HS
    Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel.
    Seiter K; Feldman EJ; Traganos F; Li X; Halicka HD; Darzynkiewicz Z; Lederman CA; Romero MB; Ahmed T
    Leukemia; 1995 Nov; 9(11):1961-6. PubMed ID: 7475290
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
    Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.